Articles tagged with Neural Stem Cells
A breakthrough technique has been developed by University of Oxford researchers to repair brain injuries using 3D printing. Neural cells can be printed to mimic the architecture of the cerebral cortex, showing structural and functional integration with host tissue.
Researchers at the University of Helsinki and NIH found that the ectoderm retains its pluripotency during gastrulation, challenging previous understanding. This discovery sheds light on the chain of events in early embryonic development and has implications for neural crest stem cell potential.
A new type of bone-forming stem cell, DDR2+, has been found to cause premature skull fusion in infants. The researchers discovered that the abnormal proliferation of this stem cell leads to an excess of bone-making cells, resulting in craniosynostosis.
Researchers found that C9ORF72 mutations impair neural stem cell renewal, leading to reduced brain regions during embryonic development. This impairment could contribute to disease symptoms later in life. The study used patient-derived nerve cells and laboratory mice to demonstrate the impact of C9ORF72 on neurodevelopment.
Researchers at CityU and HKUMed developed genetically modified human neural stem cells that promote neural circuit reconstruction, reduce glial scar accumulation, and enhance axon outgrowth. The therapy demonstrates potential for treating severe spinal cord injuries with functional recovery.
Researchers used AI to accurately classify four subtypes of Parkinson's disease from patient-derived stem cells, with one subtype reaching an accuracy of 95%. The study suggests that personalized medicine and targeted drug discovery could be possible using this approach.
Researchers at Duke University Medical Center have identified a fatty molecule in breast milk that triggers a process in which stem cells produce new white matter, reversing neurological damage. This finding holds promise for developing therapies to treat preterm babies with cerebral palsy.
Researchers found that the amyloid precursor protein (APP) regulates human neurogenesis, which could be linked to Alzheimer's disease. APP promotes a balance between stem cell proliferation and differentiation, suggesting its disruption may cause premature neurogenesis and cellular stress.
Researchers at City of Hope have developed a universal donor stem cell therapy that can treat degenerative brain diseases such as Canavan disease and Alzheimer's. The therapy, which uses an 'off-the-shelf' approach, has shown promising results in preclinical studies, reducing toxic accumulation of metabolites and improving motor function.
The study reveals that spontaneous waves of neurotransmitter glutamate facilitate dendrite pruning, while a unique protection/punishment machinery strengthens certain connections and eliminates others. Proper pruning is critical for neural development, with insufficient or excessive connections linked to neurophysiological disorders.
Scientists have developed a new method to deliver genetic information to stem cells using nanoparticles coated with a specific polymer, enabling more efficient control over cellular differentiation. This innovation has the potential to improve the efficiency and effectiveness of regenerative medicine treatments.
Scientists have created a detailed map of human spinal cord cell formation, shedding light on how injuries and diseases arise. The study's findings hold promise for developing new therapies for spinal cord injuries and diseases like ALS.
Scientists found that dopamine-containing nerve cells from Parkinson's patients have poorer ability to form extensions, leading to severe dopamine deficiency. Researchers also discovered a medication that makes these cells better at forming nerve extensions.
New research suggests neural crest cells retain adaptability even after differentiation, enabling them to 'change their mind' and differentiate anew. This hyper-flexibility has significant implications for regenerative medicine, as these cells have immense potential as treatments to replace and repair damaged body tissue.
Researchers genetically engineered neural progenitor cells to release a neuroprotective protein, preventing neuron death in animal models of ALS and retinal disease. Engineered NPCs successfully preserved vision in rats with retinal disease.
Cedars-Sinai investigators have discovered a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using human induced pluripotent stem cells. The new approach uses cells derived from iPSCs that are renewable, scalable, and can delay disease progression in rodents.
A new study from Tokyo Medical and Dental University sheds light on the neural stem cell niche's composition during development. Researchers found that vascular endothelial growth factor-A (VEGF-A) plays a crucial role in maintaining NSPCs under hypoxic conditions, promoting lower rates of cell death and increased cell proliferation.
A USC-led team of scientists identified the key gene Nr5a2, essential for opening up genome regions that enable neural crest cells to form tendons and salivary glands. Zebrafish and mice lacking this gene exhibited skeletal and tendon defects, as well as failed salivary gland development.
Researchers discovered that administration of GDF11 improves cognitive abilities and reduces depression-like behaviors in aged mice. In humans, low levels of GDF11 are associated with depressive episodes, suggesting a potential link between the protein and mood disorders.
Researchers at UNIGE and UNIL have discovered the importance of cell metabolism in reactivating quiescent neural stem cells, increasing new neurons in adult mice. This breakthrough could lead to potential treatments for conditions like depression and neurodegenerative diseases.
Researchers at Hokkaido University used hydrogel materials in combination with neural stem cells to grow new brain tissue in areas of brain damage. The study showed that immune cells and blood vessels grew within the hydrogels, leading to some degree of integration between the hydrogel and host brain tissue.
Researchers have generated large-scale muscle-controlling nerve cells from ALS patients, revealing striking differences in gene expression between males and females. The study, published in Neuron, used over 450 lines of stem cells to create motor neurons that can potentially lead to the development of new therapeutics.
Researchers from IIT have discovered a correlation between small RNA molecules, piRNAs, and brain inflammation. The study lays the groundwork for new diagnostic technologies to detect neurodegenerative diseases, such as Alzheimer's and Parkinson's, at an early stage.
The study reveals that non-coding regions near sloppy-paired genes are essential for temporal transcription factor expression and that Notch-signaling regulates the transition to subsequent TTFs. This mechanism couples temporal patterning with neuron generation, providing insights into brain diversity.
Scientists at Texas A&M University found that transplanting intestinal epithelial stem cells can repair the gut and reduce inflammation, potentially preserving cognitive function after a stroke. The study suggests that targeting gut health may be key to developing more effective stroke therapies.
Researchers used monoclonal antibodies to suppress the immune system in mice, tracking human neural stem cell survival using luciferase. The study reveals that monoclonal antibody-mediated immunosuppression enabled long-term survival of transplanted human neural stem cells in mouse brains for at least six to eight months.
Researchers discovered that cephalopods develop their large nervous systems using similar mechanisms as vertebrates, with a focus on the retina. This study provides insight into the developmental process of these intelligent creatures and could lead to new discoveries about human brain development.
Researchers discovered stem cells in mouse dorsal root ganglia (DRG) with the potential to regenerate lost sensory neurons and glia. These cells, known as satellite glia, can become activated and generate new glia and, to a lesser extent, neurons after injury.
A new stem cell study provides insight into how neurons from individuals with post-traumatic stress disorder (PTSD) respond to stress hormones. The research found that these cells are hypersensitive to the stress hormone hydrocortisone, which could help explain why some people develop PTSD after trauma exposure.
Researchers have developed brain-like organoids that can be tested experimentally to uncover cellular and molecular causes of autism. The organoids, grown in a dish from human cells, self-organize into layers of cells reminiscent of the cerebral cortex, allowing scientists to study how complex neural structures arise.
Scientists at Heidelberg University have identified a second stem cell population in the mouse brain, which is primarily involved in producing new neurons in the olfactory bulb. This discovery refutes the single stem cell type theory and suggests that both apical and basal stem cells are responsible for adult neurogenesis.
The study proposes a model to understand the complications caused by zika virus infection during pregnancy. The researchers found that zika virus alters protein expression in neural cells, affecting energy production and RNA metabolism, which can lead to defective myelination and microcephaly.
Researchers produced human and chimpanzee brain organoids to investigate the role of ARHGAP11B in brain evolution. The study found that the gene is essential for neocortex development, with its absence or inhibition leading to decreased levels of critical brain stem cells.
Researchers at the University of California, Irvine have discovered a link between Piezo1 and cholesterol levels during brain development, which may provide new avenues for treating diseases like Alzheimer's. The study found that Piezo1 influences cellular cholesterol metabolism, modulating cell quantity, quality, and organization.
Researchers studied axolotls to understand brain regeneration, finding similarities between development and regeneration processes. They discovered a rejuvenated state of development during regeneration, which could lead to improved treatments for severe injuries in humans.
A novel stem cell-gene therapy has been shown to be safe in humans, with no serious side effects reported in the first trial. The treatment targets motor neurons that die in patients with amyotrophic lateral sclerosis (ALS), a fatal neurological disorder.
Researchers have identified a group of latent stem cells in the central nervous system of mice that respond to injury by dividing, migrating towards damaged areas, and differentiating into astrocytes. If similar cells exist in humans, they could provide a new therapeutic approach for treating spinal cord injuries.
Researchers found that increasing new neurons in mice with AD rescues their memory defects by restoring neural circuits and dendritic spines. Boosting neurogenesis may be a viable strategy to treat AD patients.
A recent study by the University of Bonn found that neurons born early can develop into all types of dopaminergic neurons in the midbrain, with their career paths determined by the time of emergence. This is contrary to other nerve cells, whose order of birth determines their profession.
A new study published in Nature reveals that microglia cells change their molecular state to match neighboring neurons, influencing neural circuit function. The researchers found that different types of cortical neurons recruit specific numbers of microglia, which then adapt to the neuron's environment.
Microglia that express the APOE4 gene cannot metabolize lipids normally, leading to a buildup of excess lipids that interferes with nearby neurons' ability to communicate. Restoring normal lipid metabolism in microglia may help treat some symptoms of Alzheimer's disease.
Researchers at MPI-CBG found that modern human variants cause longer metaphase and fewer chromosome segregation errors in neural stem cells, leading to more efficient brain development. This suggests that some aspects of modern human brain evolution may be independent of brain size.
Researchers investigate astrocyte production in the brain, discovering distinct dynamics in different parts of the cortex. The study suggests that early exposure to specific genes regulates stem cell behavior, leading to variations in astrocyte generation.
Researchers developed a mathematical model to predict the efficiency of nanoparticle delivery into cells, particularly in stem cells. They found that nanoparticles become trapped in bubble-like vesicles, preventing them from reaching their targets.
Biomedical engineers have created a novel 3D synthetic structure that mimics the extracellular matrix, guiding neural progenitor cells and promoting their differentiation. The results show promise for developing brain-healing treatments, including biogels that can repair and regrow brain tissue after a stroke or other trauma.
Researchers found evidence of how destructive proteins attack human brain cells and destroy surrounding tissue. The study identified a pivotal mechanism that could be a potential therapy for the disease.
A groundbreaking study by Hebrew University researchers has discovered the most primitive blueprint for embryo cell creation. The team identified 14,000 sites in the DNA that control the development of all embryonic organs.
Researchers discovered common mutations and dysfunction in myotonic dystrophy type 1 and Rett syndrome using brain organoids. The study suggests that targeting NMDA receptors may ameliorate cognitive impairments in young patients with DM1.
Researchers developed a low-cost 3D model of the brain to study SARS-CoV-2's neurological effects. The adapted virus replicates 30 times more efficiently in astrocytes than neurons, highlighting the importance of these cells in central nervous system infection.
Researchers at Champalimaud Centre found that Wg/Wnt signaling molecule helps mount a regenerative response to brain damage. Neurons sense tissue distress, triggering dormant neural stem cells to activate and produce new neurons.
A new platform mimics live cellular environment to guide stem cell differentiation outside the body. Researchers from Chung-Ang University developed a novel platform based on metal-organic frameworks, which offers advantages over conventional methods for in vitro stem cell differentiation.
A Rutgers study analyzing brain stem cells of autism patients found irregularities in early brain development, supporting the concept that ASD arises from poor control of brain cell proliferation. The study discovered that some patients had NPCs producing too many brain cells while others had underproduced cells.
Researchers at Texas A&M University College of Medicine have identified a crucial mechanism driving the evolution of the neocortex, leading to increased intelligence and surface area. This breakthrough understanding contributes to insights into developmental deficits linked to autism spectrum disorders and intellectual disabilities.
Researchers developed an in vitro stem cell model to map disease risk variants in human neurons, which could provide insights into the biological mechanisms underlying neuropsychiatric disorders. The study focuses on mapping cis-regulatory elements linked to psychiatric disease heritability.
Two preclinical studies have identified potential new therapies for patients with Allan-Herndon-Dudley syndrome (AHDS), a brain development disorder that causes severe intellectual disability and movement problems. A gene therapy approach has shown promise in improving cognitive and motor functions, while repurposing a common drug may ...
Researchers found that jellyfish's stinging cells evolved by repurposing a neuron inherited from a pre-cnidarian ancestor. This discovery provides insights into the emergence of new cell types and the evolution of biodiversity, suggesting that co-option of ancestral cell types was an important source for new cell functions.
A receptor protein called insulin receptor is pivotal for brain stem cell longevity, according to a Rutgers study. The researchers also found that the same protein plays a crucial role in sustaining brain cancer cells.
Researchers have developed a process to convert non-neuronal cells into functioning neurons that can take up residence in the brain and restore capacities undermined by Parkinson's destruction of dopaminergic cells. In a proof-of-concept study, one group of experimentally engineered cells performs optimally in terms of survival, growth...
A new study suggests that up to 1 in 4 cases of congenital hydrocephalus may be linked to genetic mutations affecting neural stem cell growth, leading to underdeveloped brains and enlarged ventricles. This paradigm shift could lead to targeted therapies such as gene editing or drugs to optimize neurodevelopment.
Researchers at NC State University have created a stem cell-derived model that sheds light on the effect of dopamine on gene activity in neurons, revealing gene desensitization in human cells. The study provides a blueprint for future research into the relationship between dopamine and addiction.